1. Home
  2. AZTA vs PAHC Comparison

AZTA vs PAHC Comparison

Compare AZTA & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • PAHC
  • Stock Information
  • Founded
  • AZTA 1978
  • PAHC 1946
  • Country
  • AZTA United States
  • PAHC United States
  • Employees
  • AZTA N/A
  • PAHC N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTA Technology
  • PAHC Health Care
  • Exchange
  • AZTA Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • AZTA 1.4B
  • PAHC 1.2B
  • IPO Year
  • AZTA 1995
  • PAHC 2014
  • Fundamental
  • Price
  • AZTA $30.30
  • PAHC $39.45
  • Analyst Decision
  • AZTA Buy
  • PAHC Hold
  • Analyst Count
  • AZTA 4
  • PAHC 4
  • Target Price
  • AZTA $42.00
  • PAHC $27.50
  • AVG Volume (30 Days)
  • AZTA 572.0K
  • PAHC 390.6K
  • Earning Date
  • AZTA 08-05-2025
  • PAHC 08-27-2025
  • Dividend Yield
  • AZTA N/A
  • PAHC 1.22%
  • EPS Growth
  • AZTA N/A
  • PAHC 1895.04
  • EPS
  • AZTA N/A
  • PAHC 1.19
  • Revenue
  • AZTA $668,821,000.00
  • PAHC $1,296,215,000.00
  • Revenue This Year
  • AZTA N/A
  • PAHC $13.56
  • Revenue Next Year
  • AZTA $4.18
  • PAHC $3.06
  • P/E Ratio
  • AZTA N/A
  • PAHC $33.14
  • Revenue Growth
  • AZTA 12.46
  • PAHC 27.37
  • 52 Week Low
  • AZTA $23.91
  • PAHC $16.16
  • 52 Week High
  • AZTA $55.64
  • PAHC $39.91
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 49.10
  • PAHC 75.82
  • Support Level
  • AZTA $28.58
  • PAHC $34.65
  • Resistance Level
  • AZTA $30.59
  • PAHC $39.91
  • Average True Range (ATR)
  • AZTA 0.98
  • PAHC 1.75
  • MACD
  • AZTA 0.01
  • PAHC 0.71
  • Stochastic Oscillator
  • AZTA 53.42
  • PAHC 95.17

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: